Detalhe da pesquisa
1.
Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping.
Nat Cancer
; 5(1): 114-130, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38177459
2.
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer.
Nat Commun
; 15(1): 1828, 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38418825
3.
Genomic Features of Lung-Recurrent Hormone-Sensitive Prostate Cancer.
JCO Precis Oncol
; 6: e2100543, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35507889
4.
Development of secondary urothelial carcinoma following complete response to immune checkpoint inhibitors.
Urol Case Rep
; 39: 101762, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34258232
5.
BRCA2, ATM, and CDK12 Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical Aggression.
Clin Cancer Res
; 27(6): 1650-1662, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33414135
6.
Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer.
Nat Commun
; 12(1): 184, 2021 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33420073
7.
Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer.
Eur Urol
; 78(6): 834-844, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32451180
8.
Identification of Hypermutation and Defective Mismatch Repair in ctDNA from Metastatic Prostate Cancer.
Clin Cancer Res
; 26(5): 1114-1125, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31744831